Jazz Closes Acquisition of Azur Pharma
Jan 20, 2012
By joe , manufacturingchemist.com
Tag: biopharmaceutical company,merger, Ireland
Jazz Pharmaceuticals has bought Irish firm Azur Pharma in a deal that creates a specialty drug company headquartered in Dublin.
US drugmaker Jazz Pharmaceuticals Inc said Wednesday it has concluded its merger with privately held Azur Pharma to create a specialist biopharmaceutical company called Jazz Pharmaceuticals plc.
The new firm is based in Dublin, Ireland, with operations in Palo Alto, California and Philadelphia, Pennsylvania in the US.
Jazz Pharmaceuticals plc employs around 430 people, including a commercial organisation focused on four key areas: narcolepsy, severe chronic pain, psychiatry and a diversified portfolio of women's health products.
The firm expects to have revenues of more than US$475m and generate cash of more than $200m in the first 12 months following the closure of the deal.
If you believe an article violates your rights or the rights of others, please contact us.
